Pa. Transit Agency Slaps Gilead With Price-Gouging Suit
A Pennsylvania transportation agency has hit Gilead Sciences Inc. with a class action over its hepatitis C drug Sovaldi, claiming that the pharmaceutical giant is maintaining a questionable monopoly on the...To view the full article, register now.
Already a subscriber? Click here to view full article